A recent report highlighted that phosphorylation of PTEN at tyrosine 240 (pY240) by fibroblast growth factor receptor 2 (FGFR2) mediates radiotherapy (RT) resistance in GBM [15]. Here, FGFR2 is linked to glioblastoma.